Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2439431000168119 | Ursosan (ursodeoxycholic acid 250 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2439441000168111 | Ursosan 250 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ursosan 250 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Ursosan 250 mg capsule | has Australian BoSS | ursodeoxycholic acid | true | Inferred relationship | Some | 1183108126 | |
| Ursosan 250 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1183108127 | |
| Ursosan 250 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ursosan 250 mg capsule | Is a | Ursosan | true | Inferred relationship | Some | ||
| Ursosan 250 mg capsule | Is a | ursodeoxycholic acid 250 mg capsule | true | Inferred relationship | Some | ||
| Ursosan 250 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Ursosan 250 mg capsule | has intended active ingredient | ursodeoxycholic acid | true | Inferred relationship | Some | 1183108126 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ursosan 250 mg capsule, 100, blister pack | has TPUU | True | Ursosan 250 mg capsule | Inferred relationship | Some | 1 |
| Ursosan 250 mg capsule, 100 | has TPUU | True | Ursosan 250 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR